Skip to main content
. 2020 Oct 13;13:10315–10322. doi: 10.2147/OTT.S255586

Figure 1.

Figure 1

Delicaflavone united with DDP could reduced the cell viability of lung cancer DDP resistant cells. (A) the cell viability of A549 and A549/DDP cells were detected with the concentrations of DDP for 24h. (B) the cell viability of PC9 and PC9/DDP cells were detected with the concentrations of DDP for 24h. (C) the cell viability of A549 and A549/DDP cells were detected with the concentrations of Delicaflavone for 24 h. (D) the cell viability of PC9 and PC9/DDP cells were detected with the concentrations of Delicaflavone for 24 h. (E) A549/DDP cells were treated with 20 µM Delicaflavone combined with indicated concentrations of DDP for 24 h. (F) PC9/DDP cells were treated with 20 µM Delicaflavone combined with indicated concentrations of DDP for 24 h. (G) the cell viability of A549/DDP cells were detected by CCK8 at the concentrations of Delicaflavone (20 µM) or DDP (16 µM) or Delicaflavone (20 µM)+DDP (16 µM) for 24h, 48h, 72 h. (H) the cell viability of PC9/DDP cells were detected by CCK8 at the concentrations of Delicaflavone (20 µM) or DDP (16 µM) or Delicaflavone (20 µM)+DDP (16 µM) for 24h, 48h, 72 h. Data represent mean ± SD. *P < 0.05. #P < 0.05 represents compared with the Delicaflavone alone group or DDP alone group.